| Page 1287 | Kisaco Research
 

Don McCombie

Partner
Clifford Chance

Don McCombie is a partner in the London IP group at Clifford Chance. He advises on all aspects of IP law, in particular technical trade secrets and patent disputes. In recent years, Don has brought and defended trade secrets claims relating to technologies including cryptocurrency trading software, semiconductor designs, antibody libraries, fire-resistant coatings and liners for train gondola wagons, as well as business information and datasets.

Don McCombie

Partner
Clifford Chance

Don McCombie

Partner
Clifford Chance

Don McCombie is a partner in the London IP group at Clifford Chance. He advises on all aspects of IP law, in particular technical trade secrets and patent disputes. In recent years, Don has brought and defended trade secrets claims relating to technologies including cryptocurrency trading software, semiconductor designs, antibody libraries, fire-resistant coatings and liners for train gondola wagons, as well as business information and datasets. Don also regularly advises on the licensing and transfer of trade secrets and know-how and on practical strategies for protecting information and reducing the risk of trade secrets theft.

 

Caterina Strippoli

Head of Intellectual Property
Enel Group

Caterina Strippoli

Head of Intellectual Property
Enel Group

Caterina Strippoli

Head of Intellectual Property
Enel Group
 

Zheng Zhou

Group Legal Counsel
Volkswagen AG

Zheng Zhou

Group Legal Counsel
Volkswagen AG

Zheng Zhou

Group Legal Counsel
Volkswagen AG
 

Niels Junge

IPR Manager
Ørsted A/S

Niels Junge

IPR Manager
Ørsted A/S

Niels Junge

IPR Manager
Ørsted A/S
 

David Blackwell

Senior Director, Global Black Community External Impact Pillar Lead
Pfizer

David Blackwell

Senior Director, Global Black Community External Impact Pillar Lead
Pfizer

David Blackwell

Senior Director, Global Black Community External Impact Pillar Lead
Pfizer
 

Linda Goler Blount

Chief Executive Officer
Black Women’s Health Imperative

Linda Goler Blount

Chief Executive Officer
Black Women’s Health Imperative

Linda Goler Blount

Chief Executive Officer
Black Women’s Health Imperative
 

Jocelyn Ashford

Vice President of patient advocacy
BridgeBio

Jocelyn Ashford

Vice President of patient advocacy
BridgeBio

Jocelyn Ashford

Vice President of patient advocacy
BridgeBio
 

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

A passionate advocate for health equity, Brittany is dedicated to promoting health equity and representation in clinical research. She actively participates in discussions and panels focused on equity in clinical trials, sharing her knowledge and strategies for fostering inclusivity. Her leadership and commitment to ensuring representation in clinical research plays a pivotal role in advancing health outcomes for all communities, building trust, and making medical innovations accessible to everyone.